Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2-Reference-Cited by-同舟云学术

Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2

Published:2021-10-15 Issue: Volume: Page:
ISSN:1138-7548
Container-title:Journal of Physiology and Biochemistry
language:en
Short-container-title:J Physiol Biochem

Author:

Shatoor Abdullah S.,Al Humayed Suliman,Almohiy Hussain M.

Funder

Deanship of Scientific Research, King Khalid University

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Biochemistry,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s13105-021-00850-9.pdf

Reference111 articles.

1. Abenavoli, L, Greco, M, Milic, N, Accattato, F, Foti, D, Gulletta, E, & Luzza, F (2017) Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients 9(8). https://doi.org/10.3390/nu9080870

2. Ambati RR, Phang SM, Ravi S, Aswathanarayana RG (2014) Astaxanthin: sources, extraction, stability, biological activities and its commercial applications–a review. Mar Drugs 12(1):128–152. https://doi.org/10.3390/md12010128

3. Arunkumar E, Bhuvaneswari S, Anuradha CV (2012) An intervention study in obese mice with astaxanthin, a marine carotenoid–effects on insulin signaling and pro-inflammatory cytokines. Food Funct 3(2):120–126. https://doi.org/10.1039/c1fo10161g

4. Asrih M, Jornayvaz FR (2013) Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 218(3):R25-36. https://doi.org/10.1530/joe-13-0201

5. Athyros VG, Boutari C, Stavropoulos K, Anagnostis P, Imprialos KP, Doumas M, Karagiannis A (2018) Statins: an under-appreciated asset for the prevention and the treatment of NAFLD or NASH and the related cardiovascular risk. Curr Vasc Pharmacol 16(3):246–253. https://doi.org/10.2174/1570161115666170621082910

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications;Human Nutrition & Metabolism;2024-09

2. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

3. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment;Journal of Physiology and Biochemistry;2024-08-14

4. Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds;Heliyon;2024-08

5. Endoplasmic reticulum stress: bridging inflammation and obesity-associated adipose tissue;Frontiers in Immunology;2024-04-04